Leerink Partners Downgrades CureVac (CVAC) to Market Perform
Tweet
Share
E-mailGet Alerts CVAC Hot Sheet
Price: $4.66 --0%
Rating Summary:
1 Buy, 6 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
1 Buy, 6 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Leerink Partners analyst Mani Foroohar downgraded CureVac (NASDAQ: CVAC) from Outperform to Market Perform with a price target of $4.00.
For an analyst ratings summary and ratings history on CureVac click here. For more ratings news on CureVac click here.
Shares of CureVac closed at $2.51 yesterday.
You May Also Be Interested In
- RBC Capital Downgrades Accelerant Holdings (ARX) to Sector Perform
- Goldman Sachs Downgrades Douglas AG (DOU:GR) to Sell
- UBS Downgrades ASX Limited (ASX:AU) (ASXFY) to Neutral
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
